Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.

@article{Wang2009ClinicalSA,
  title={Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.},
  author={Qiuyue Wang and Fen-qin Chen},
  journal={Diabetes research and clinical practice},
  year={2009},
  volume={83 2},
  pages={215-9}
}
OBJECTIVE Monocyte chemoattractant protein-1(MCP-1) is a cytokine that exhibits most potent chemotactic activity toward monocytes. It is suggested to be implicated in the development and progression of diabetic nephropathy by playing a role in infiltration of monocyte/macrophage. Recent studies have demonstrated that urinary monocyte chemoattractant protein-1 (uMCP-1) is different at different stages of diabetic nephropathy. Based on these findings, the aim of this study is to examine the level… CONTINUE READING